Cargando…

Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference

OBJECTIVES: To evaluate the value of computed tomography (CT) enhancement degree in diagnosing lymph node (LN) metastasis in papillary thyroid carcinoma (PTC) by determining the ratio and difference between the Hounsfield units (HU) of CT enhancement and plain scan of the LNs, as well as between the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jiying, Tian, Min, Zhang, Tong, Zhu, Hanlin, Wei, Peiying, Han, Zhijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073713/
https://www.ncbi.nlm.nih.gov/pubmed/37033256
http://dx.doi.org/10.3389/fendo.2023.1103434
_version_ 1785019630035664896
author Zhu, Jiying
Tian, Min
Zhang, Tong
Zhu, Hanlin
Wei, Peiying
Han, Zhijiang
author_facet Zhu, Jiying
Tian, Min
Zhang, Tong
Zhu, Hanlin
Wei, Peiying
Han, Zhijiang
author_sort Zhu, Jiying
collection PubMed
description OBJECTIVES: To evaluate the value of computed tomography (CT) enhancement degree in diagnosing lymph node (LN) metastasis in papillary thyroid carcinoma (PTC) by determining the ratio and difference between the Hounsfield units (HU) of CT enhancement and plain scan of the LNs, as well as between the HU of CT-enhanced LNs and the sternocleidomastoid muscle. METHODS: The plain and enhanced CT findings of 114 metastasis-positive LNs in 89 cases and 143 metastasis-negative LNs in 114 cases of PTC were analyzed retrospectively. Plain HU of LNs (PN(HU)), enhanced HU of LNs (EN(HU)), and enhanced HU of the sternocleidomastoid muscle (EM(HU)) were measured. The EN(HU), difference between EN(HU) and PN(HU) (EN-PN(HU)), ratio of EN(HU) to PN(HU) (EN/PN(HU)), difference between EN(HU) and EM(HU) (EN-EM(HU)), and ratio of EN(HU) to EM(HU) (EN/EM(HU)) in metastasis-positive and metastasis-negative LN groups were calculated, the corresponding diagnostic efficacy for differentiating metastasis-positive from metastasis-negative LNs in PTC were sought using the receiver-operating curve. The interobserver agreement between readers was assessed using the interobserver correlation coefficient (ICC). RESULTS: The EN(HU) of 114 metastasis-positive LNs and 143 metastasis-negative LNs was 113.39 ± 24.13 and 77.65 ± 15.93, EN-PN(HU) was 65.84 ± 21.72 HU and 34.07 ± 13.63 HU, EN/PN(HU) was 2.36 (1.98, 2.75) and 1.76 (1.54, 2.02), EN-EM(HU) was 49.42 ± 24.59 HU and 13.27 ± 15.41 HU, and EN/EM(HU) was 1.79 ± 0.40 and 1.21 ± 0.24, respectively (all P < 0.001). The area under the curve, cutoff value, sensitivity, specificity, and accuracy of EN(HU) for identifying metastasis-positive and metastasis-negative LNs were 0.895, 97.3 HU, 0.746, 0.895, and 0.829, EN-PN(HU) was 0.894, 47.8 HU, 0.807, 0.874, and 0.844, EN/PN(HU) was 0.831, 1.9, 0.877, 0.650, and 0.751, EN-EM(HU) was 0.890, 26.4 HU, 0.807, 0.839, and 0.825, and EN/EM(HU) was 0.888, 1.5, 0.728, 0.902, and 0.825, respectively. The readers had an excellent interobserver agreement on these five parameters (ICC = 0.874–0.994). CONCLUSION: In the preoperative evaluation of LN metastasis in PTC, EN(HU), EN-PN(HU), EN-EM(HU), and EN/EM(HU) had similarly high diagnostic efficacy, with EN(HU), EN-PN(HU), and EN/EM(HU) having higher specificity and EN-PN(HU) and EN-EM(HU) having higher sensitivity.
format Online
Article
Text
id pubmed-10073713
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100737132023-04-06 Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference Zhu, Jiying Tian, Min Zhang, Tong Zhu, Hanlin Wei, Peiying Han, Zhijiang Front Endocrinol (Lausanne) Endocrinology OBJECTIVES: To evaluate the value of computed tomography (CT) enhancement degree in diagnosing lymph node (LN) metastasis in papillary thyroid carcinoma (PTC) by determining the ratio and difference between the Hounsfield units (HU) of CT enhancement and plain scan of the LNs, as well as between the HU of CT-enhanced LNs and the sternocleidomastoid muscle. METHODS: The plain and enhanced CT findings of 114 metastasis-positive LNs in 89 cases and 143 metastasis-negative LNs in 114 cases of PTC were analyzed retrospectively. Plain HU of LNs (PN(HU)), enhanced HU of LNs (EN(HU)), and enhanced HU of the sternocleidomastoid muscle (EM(HU)) were measured. The EN(HU), difference between EN(HU) and PN(HU) (EN-PN(HU)), ratio of EN(HU) to PN(HU) (EN/PN(HU)), difference between EN(HU) and EM(HU) (EN-EM(HU)), and ratio of EN(HU) to EM(HU) (EN/EM(HU)) in metastasis-positive and metastasis-negative LN groups were calculated, the corresponding diagnostic efficacy for differentiating metastasis-positive from metastasis-negative LNs in PTC were sought using the receiver-operating curve. The interobserver agreement between readers was assessed using the interobserver correlation coefficient (ICC). RESULTS: The EN(HU) of 114 metastasis-positive LNs and 143 metastasis-negative LNs was 113.39 ± 24.13 and 77.65 ± 15.93, EN-PN(HU) was 65.84 ± 21.72 HU and 34.07 ± 13.63 HU, EN/PN(HU) was 2.36 (1.98, 2.75) and 1.76 (1.54, 2.02), EN-EM(HU) was 49.42 ± 24.59 HU and 13.27 ± 15.41 HU, and EN/EM(HU) was 1.79 ± 0.40 and 1.21 ± 0.24, respectively (all P < 0.001). The area under the curve, cutoff value, sensitivity, specificity, and accuracy of EN(HU) for identifying metastasis-positive and metastasis-negative LNs were 0.895, 97.3 HU, 0.746, 0.895, and 0.829, EN-PN(HU) was 0.894, 47.8 HU, 0.807, 0.874, and 0.844, EN/PN(HU) was 0.831, 1.9, 0.877, 0.650, and 0.751, EN-EM(HU) was 0.890, 26.4 HU, 0.807, 0.839, and 0.825, and EN/EM(HU) was 0.888, 1.5, 0.728, 0.902, and 0.825, respectively. The readers had an excellent interobserver agreement on these five parameters (ICC = 0.874–0.994). CONCLUSION: In the preoperative evaluation of LN metastasis in PTC, EN(HU), EN-PN(HU), EN-EM(HU), and EN/EM(HU) had similarly high diagnostic efficacy, with EN(HU), EN-PN(HU), and EN/EM(HU) having higher specificity and EN-PN(HU) and EN-EM(HU) having higher sensitivity. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073713/ /pubmed/37033256 http://dx.doi.org/10.3389/fendo.2023.1103434 Text en Copyright © 2023 Zhu, Tian, Zhang, Zhu, Wei and Han https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhu, Jiying
Tian, Min
Zhang, Tong
Zhu, Hanlin
Wei, Peiying
Han, Zhijiang
Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference
title Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference
title_full Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference
title_fullStr Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference
title_full_unstemmed Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference
title_short Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference
title_sort diagnostic value of ct enhancement degree in lymph node metastasis of papillary thyroid cancer: a comparison of enhancement, ratio, and difference
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073713/
https://www.ncbi.nlm.nih.gov/pubmed/37033256
http://dx.doi.org/10.3389/fendo.2023.1103434
work_keys_str_mv AT zhujiying diagnosticvalueofctenhancementdegreeinlymphnodemetastasisofpapillarythyroidcanceracomparisonofenhancementratioanddifference
AT tianmin diagnosticvalueofctenhancementdegreeinlymphnodemetastasisofpapillarythyroidcanceracomparisonofenhancementratioanddifference
AT zhangtong diagnosticvalueofctenhancementdegreeinlymphnodemetastasisofpapillarythyroidcanceracomparisonofenhancementratioanddifference
AT zhuhanlin diagnosticvalueofctenhancementdegreeinlymphnodemetastasisofpapillarythyroidcanceracomparisonofenhancementratioanddifference
AT weipeiying diagnosticvalueofctenhancementdegreeinlymphnodemetastasisofpapillarythyroidcanceracomparisonofenhancementratioanddifference
AT hanzhijiang diagnosticvalueofctenhancementdegreeinlymphnodemetastasisofpapillarythyroidcanceracomparisonofenhancementratioanddifference